TYMS and neoplasm: Raltitrexed, also known as ZD1694 or Tomudex®, is a specific thymidylate synthase (TS) inhibitor that can reduce the proliferation of tumor cells by arresting the cell cycle in the G0/G1 phase and by inducing tumor cell apoptosis through the mitochondrial pathway [5, 6].